0.05). However, the natalizumab-treated group had a significantly lower birth weight than the control group (MD=-97.89; 95 percent CI=-171.32, -24.45), with 82.7% relapse rate (95 percent CI= 72.1-89.8), being highest in the second trimester (24.9%; 95% CI= 7.4, 58.0). Conclusion: While Natalizumab treatment appears to be relatively safe in terms of abortion rates, C-section rates, preterm delivery rates, and congenital anomalies, the increased relapse rate during pregnancy and lower birth weight observed necessitate careful monitoring and individualized care for pregnant MS patients taking natalizumab."/>
E-ISSN 1658-7820
 
2024, Vol: 8, Issue: 5
8 / 5Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

Review Article

Online Publishing Date:
18 / 03 / 2024

 


Natalizumab intake during pregnancy in women with multiple sclerosis: A meta-analysis of current evidence

Abdulrahman Abdullah Al Malki, Alaa Saleh Albrakaty Alsharif, Khlood Fayez Aburaya, Sheema Iqbal Cheema, Ashwaq Khader Alharthi, Abeer Awadh Althobaiti.


Abstract
Background:
Disease-modified therapy has changed the previous practice of discontinuing multiple sclerosis (MS) treatment for fear of side effects that might impact pregnancy. Many studies have described the use of natalizumab as a medicinal agent during pregnancy, with mixed results regarding its safety and efficacy during pregnancy. For instance, this study aimed to investigate the pregnancy outcomes in pregnant women with MS who took natalizumab during the pregnancy period.
Methods:
A systematic literature search was conducted during July 2023, adhering to the PRISMA guidelines. Five databases were included: PubMed, Google Scholar, Web of Science, Virtual Health Library, and Scopus. The following keywords were employed in the search "multiple sclerosis," "pregnancy," "pregnancies, "pregnant," and "natalizumab".
Results:
Only eight papers out of 1,000 total records were included. No significant difference between natalizumab and the control group in terms of abortion, c-section, preterm birth, congenital abnormalities, or birth height was found (p> 0.05). However, the natalizumab-treated group had a significantly lower birth weight than the control group (MD=-97.89; 95 percent CI=-171.32, -24.45), with 82.7% relapse rate (95 percent CI= 72.1-89.8), being highest in the second trimester (24.9%; 95% CI= 7.4, 58.0).
Conclusion:
While Natalizumab treatment appears to be relatively safe in terms of abortion rates, C-section rates, preterm delivery rates, and congenital anomalies, the increased relapse rate during pregnancy and lower birth weight observed necessitate careful monitoring and individualized care for pregnant MS patients taking natalizumab.

Key words: Natalizumab intake, pregnancy, multiple sclerosis, meta-analysis, Saudi Arabia


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Abdulrahman Abdullah Al Malki
Articles by Alaa Saleh Albrakaty Alsharif
Articles by Khlood Fayez Aburaya
Articles by Sheema Iqbal Cheema
Articles by Ashwaq Khader Alharthi
Articles by Abeer Awadh Althobaiti
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Malki AAA, Alsharif ASA, Aburaya KF, Cheema SI, Alharthi AK, Althobaiti AA. Natalizumab intake during pregnancy in women with multiple sclerosis: A meta-analysis of current evidence. IJMDC. Online First: 18 Mar, 2024. doi:10.24911/IJMDC.51-1708189353

Web Style

Malki AAA, Alsharif ASA, Aburaya KF, Cheema SI, Alharthi AK, Althobaiti AA. Natalizumab intake during pregnancy in women with multiple sclerosis: A meta-analysis of current evidence. https://www.ijmdc.com/?mno=191273 [Access: March 26, 2024]. doi:10.24911/IJMDC.51-1708189353

AMA (American Medical Association) Style

Malki AAA, Alsharif ASA, Aburaya KF, Cheema SI, Alharthi AK, Althobaiti AA. Natalizumab intake during pregnancy in women with multiple sclerosis: A meta-analysis of current evidence. IJMDC. Online First: 18 Mar, 2024. doi:10.24911/IJMDC.51-1708189353


Vancouver/ICMJE Style

Malki AAA, Alsharif ASA, Aburaya KF, Cheema SI, Alharthi AK, Althobaiti AA. Natalizumab intake during pregnancy in women with multiple sclerosis: A meta-analysis of current evidence. IJMDC, [cited March 26, 2024]; Online First: 18 Mar, 2024. doi:10.24911/IJMDC.51-1708189353


Harvard Style

Malki, A. A. A., Alsharif, . A. S. A., Aburaya, . K. F., Cheema, . S. I., Alharthi, . A. K. & Althobaiti, . A. A. (2024) Natalizumab intake during pregnancy in women with multiple sclerosis: A meta-analysis of current evidence. IJMDC, Online First: 18 Mar, 2024. doi:10.24911/IJMDC.51-1708189353


Turabian Style

Malki, Abdulrahman Abdullah Al, Alaa Saleh Albrakaty Alsharif, Khlood Fayez Aburaya, Sheema Iqbal Cheema, Ashwaq Khader Alharthi, and Abeer Awadh Althobaiti. 2024. Natalizumab intake during pregnancy in women with multiple sclerosis: A meta-analysis of current evidence. International Journal of Medicine in Developing Countries, Online First: 18 Mar, 2024. doi:10.24911/IJMDC.51-1708189353


Chicago Style

Malki, Abdulrahman Abdullah Al, Alaa Saleh Albrakaty Alsharif, Khlood Fayez Aburaya, Sheema Iqbal Cheema, Ashwaq Khader Alharthi, and Abeer Awadh Althobaiti. "Natalizumab intake during pregnancy in women with multiple sclerosis: A meta-analysis of current evidence." International Journal of Medicine in Developing Countries Online First: 18 Mar, 2024. doi:10.24911/IJMDC.51-1708189353


MLA (The Modern Language Association) Style

Malki, Abdulrahman Abdullah Al, Alaa Saleh Albrakaty Alsharif, Khlood Fayez Aburaya, Sheema Iqbal Cheema, Ashwaq Khader Alharthi, and Abeer Awadh Althobaiti. "Natalizumab intake during pregnancy in women with multiple sclerosis: A meta-analysis of current evidence." International Journal of Medicine in Developing Countries Online First: 18 Mar, 2024. Web. 26 Mar 2024 doi:10.24911/IJMDC.51-1708189353


APA (American Psychological Association) Style

Malki, A. A. A., Alsharif, . A. S. A., Aburaya, . K. F., Cheema, . S. I., Alharthi, . A. K. & Althobaiti, . A. A. (2024) Natalizumab intake during pregnancy in women with multiple sclerosis: A meta-analysis of current evidence. International Journal of Medicine in Developing Countries, Online First: 18 Mar, 2024. doi:10.24911/IJMDC.51-1708189353




Most Viewed Articles
Most Accessed Articles

  • Marginal adaptation of fixed prosthodontics
    Shahad Mohammed Halawani, Sahar Amer Al-Harbi
    IJMDC. 2017; 1(2): 78-84
    » Abstract » doi: 10.24911/IJMDC.1.2.7

  • Parasites in central nervous system
    Amal Ahmed Mohamed, Asmaa Mohamed Mansour
    IJMDC. 2017; 1(2): 72-77
    » Abstract » doi: 10.24911/IJMDC.1.2.6

  • Non-diabetic retinopathy: a case report
    Hassan F. Alkwikbi, Nabil Mamon Abdelfattah, Haithem Mamon Abdelfattah
    IJMDC. 2017; 1(1): 33-37
    » Abstract » doi: 10.24911/IJMDC.1.1.6

  • Vitamin D deficiency among high school female students in Riyadh
    Sahar Mohsen Aldhafeeri, Fatemah Ibraheem Alrawaji, Abrar Mubarak Algharbi, Alanoud Abdullah Alhessan, Ayat Sami Qabaja, Ghaleah Abdulaziz Alnassar, Ghaliah Ofayn Alsulami, Mashael Belal Alrubaian, Norah Abdulaziz Alhatim, Salehah Salih Alotaibi, Zahra Ali Alkhamees
    IJMDC. 2017; 1(1): 18-23
    » Abstract » doi: 10.24911/IJMDC.1.1.4

  • Prognosis of chronic complications of diabetes mellitus (DM) after multiple events of diabetic ketoacidosis (DKA)
    Baraa Faiez Rajab, Anwar Essa Alamrim, Ali Essa Alamri
    IJMDC. 2019; 3(5): 474-479
    » Abstract » doi: 10.24911/IJMDC.51-1546551993

    •
    Most Downloaded
    Top Downloaded Articles

  • Anti-IL-17 markedly inhibited the in vitro granuloma induced by Schistosoma mansoni soluble egg antigen.
    Asmaa Ezz, Irene S. Gmail, Fatma Elzahraa H. Salem, Rabab Salama, Soad Nady
    IJMDC. 2018; 2(January 2018): 38-46
    » Abstract » doi: 10.24911/IJMDC.2.1.7

  • Vitamin D deficiency among high school female students in Riyadh
    Sahar Mohsen Aldhafeeri, Fatemah Ibraheem Alrawaji, Abrar Mubarak Algharbi, Alanoud Abdullah Alhessan, Ayat Sami Qabaja, Ghaleah Abdulaziz Alnassar, Ghaliah Ofayn Alsulami, Mashael Belal Alrubaian, Norah Abdulaziz Alhatim, Salehah Salih Alotaibi, Zahra Ali Alkhamees
    IJMDC. 2017; 1(1): 18-23
    » Abstract » doi: 10.24911/IJMDC.1.1.4

  • Antibiotic Resistance Crisis
    Nuha Saad Mobarki, Buthaina Abdullah Almerabi, Ahmad Hattan Hattan
    IJMDC. 2019; 3(6): 561-564
    » Abstract » doi: 10.24911/IJMDC.51-1549060699

  • The knowledge of mothers about children malnutrition and associated factors
    Anas Abdulrahman Aljohani, Mujahid Abdulrahman Aljohani
    IJMDC. 2020; 4(1): 7-11
    » Abstract » doi: 10.24911/IJMDC.51-1541620358

  • Knowledge and attitude of caregivers of cerebral palsy children in Riyadh city
    Abdulaziz Alruwaished, Baleegh Ali, Lubna Abdullah Alhowaimil , Abaraa adullah Alhowaimil, Najd Abdullah Alhowaimil, Aminah Alessa
    IJMDC. 2020; 4(1): 12-17
    » Abstract » doi: 10.24911/IJMDC.51-1547833051

    •
    Most Cited Articles
    Most Cited Articles

  • Antibiotic Resistance Crisis
    Nuha Saad Mobarki, Buthaina Abdullah Almerabi, Ahmad Hattan Hattan
    IJMDC. 2019; 3(6): 561-564
    » Abstract » doi: 10.24911/IJMDC.51-1549060699
    Cited : 34 times [Click to see citing articles]

  • Prevalence of depression, anxiety and stress among diabetes mellitus patients in Arar, Northern Saudi Arabia
    AMohammed Elamin Mukrim, Nujud Muteb D. Alshammari, Wurud Muteb D. Alshammari, Maali Subhi T. Alshammari, Yousef Nasif R. Alshammari, Abdulaziz Sael M. Alshammari, Maisa Hamad F. Alanazi, Abdulelah Abdulrhman F. Alzammam, Muharib Mana M. Alshammari, Slwa Khaled Abu Asyah, Aseel Jamal Alzuhayri, Mushref Saeid Alshammari
    IJMDC. 2019; 3(3): 229-233
    » Abstract » doi: 10.24911/IJMDC.51-1542576396
    Cited : 8 times [Click to see citing articles]

  • Knowledge, attitude, and practice of breast self-examination toward breast cancer among female students at King Saud University in Riyadh, Saudi Arabia
    Abdullah Nasser Alomair, Dania Ghazi Felemban, Mohannad Sami Felemban, Jameel Abdullah Awadain, Ammar Saud Altowairqi, Nawaf Fawzan Alfawzan, Fatimah Mohammed Almazayen, Abdulrahman Jalwi Korkoman, Nawaf Saad Alrusayyis
    IJMDC. 2020; 4(2): 429-434
    » Abstract » doi: 10.24911/IJMDC.51-1576668182
    Cited : 8 times [Click to see citing articles]

  • Population awareness about rheumatoid arthritis in Jazan region, Saudi Arabia
    Ahmad Ali Hazzazi, Mohssen Hassen Ageeli, Ahmed Ali Muyidi, Abdulaziz Mohammad Abulgasim, Abdullah Ahmad Yateemi, Nabil Alhakami
    IJMDC. 2020; 4(3): 668-675
    » Abstract » doi: 10.24911/IJMDC.51-1576010943
    Cited : 4 times [Click to see citing articles]

  • Prevalence and factors associated with depression among health care workers in National Guard Hospital in Riyadh, KSA
    Noor Mohammad AlFahhad
    IJMDC. 2018; 2(September 2018): 92-96
    » Abstract » doi: 10.24911/IJMDC.51-1526306040
    Cited : 4 times [Click to see citing articles]

    •

    About International Journal of Medicine in Developing Countries

    International Journal of Medicine in Developing Countries is a peer-reviewed, open access international medical journal. Journal Title Internat ... Read more.



    For best results, please use Internet Explorer or Google Chrome.

    Contact Information

    Publisher: Discover STM Publishing Ltd. 164 Moyville. Rathfarnham, Dublin, D16Y4E, Ireland

    Hours:  M-F: 7:30am - 4:30pm 

    Fax: +353 (0)1 633 5037 

    Emails:

    Journal Editorial Office:  contact@ijmdc.com

    All queries regarding the publishing or accepting of the manuscript should be directed to the Journal Editorial Office at Riyadh, Saudi Arabia. 

    Publishing and Hosting service is provided by Discover STM (Ireland):  contact@discoverpublish.com
    POLICIES & JOURNAL LINKS
    Author Login
    Reviewer Login
    About Publisher
    Advertising Policy
    Author's Rights and Obligations
    Conflict of Interest Policy
    Copyright Information
    Digital Archiving & Preservation Policies
    Editorial Policies
    Peer Review Policy
    Editorial & Peer Review Process
    License Information
    Open Access Policy
    Plagiarism Policy
    Privacy Policy
    Protection of Research Participants (Statement On Human And Animal Rights)
    Publication Ethics and Publication Malpractice Statement
    Corrections, Retractions & Expressions of Concern
    Self-Archiving Policies
    Statement of Informed Consent
    Terms of Use